Editorial (Thematic Issue: Metabolic Disorders, Drug Development, Drug Design and Biomarkers)

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|22|7|765-767

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.22, Iss.7, 2016-02, pp. : 765-767

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Editorial (Thematic Issue: Emerging Biomarkers for Drug Development in Amyotrophic Lateral Sclerosis)

By  

Current Medicinal Chemistry, Vol. 21, Iss. 31, 2014-10 ,pp. : 3507-3507

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial (Thematic Issue: Neurodegeneration, Oxidative Stress, Metabolic Syndrome, Drug Design and Development: Clinical Implications)

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 15, Iss. 2, 2016-03 ,pp. : 126-126

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial (Thematic Issue: GPCR-Targeted Drug Development)

By  

Current Drug Targets, Vol. 17, Iss. 5, 2016-04 ,pp. : 486-487

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial (Thematic Issue: HSA-Based Drug Development and Drug Delivery Systems)

By  

Current Pharmaceutical Design, Vol. 21, Iss. 14, 2015-04 ,pp. : 1784-1784

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial (Thematic Issue: Clinical Use of Biomarkers in Drug Metabolism and Adverse Drug Reactions)

By  

Current Drug Metabolism, Vol. 15, Iss. 2, 2014-02 ,pp. : 127-128

Bentham Science Publishers

Access to resources Recommend Favorite